海普瑞(002399)

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
深圳市海普瑞药业集团股份有限公司
所属行业
医药制造业
上市日期
2010-05-06
注册资本
146729万元
公司概况
深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。

暂不提供行情数据

热议股票

{"pagemeta":{"title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,002399,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"002399","data":{"stockData":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":11.43,"timestamp":1773385386000,"preClose":11.38,"halted":0,"volume":3551700,"delay":0,"changeRate":0.0044,"floatShares":1247000000,"shares":1467000000,"eps":0.2864,"marketStatus":"已收盘","change":0.05,"latestTime":"03-13 15:00:00","open":11.4,"high":11.56,"low":11.39,"amount":40795600,"amplitude":0.0149,"askPrice":11.43,"askSize":9,"bidPrice":11.42,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.2864,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773624600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.38,"symbolType":"stock","openAndCloseTimeList":[[1773365400000,1773372600000],[1773378000000,1773385200000]],"highLimit":12.52,"lowLimit":10.24,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1467296204,"isCdr":false,"pbRate":1.35,"roa":"--","peRate":39.909218,"roe":"4.51%","epsLYR":0.4408,"committee":0.006135,"marketValue":16771000000,"turnoverRate":0.0028,"status":0,"hkstockBrief":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":5.16,"timestamp":1773389299168,"preClose":5.2,"halted":0,"volume":463000,"delay":0,"premium":"-60.21"},"floatMarketCap":14256000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"serverTime":1773395762987,"stockEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":-0.0815},{"period":"3month","weight":-0.0215},{"period":"6month","weight":-0.1151},{"period":"1year","weight":0.0574},{"period":"ytd","weight":-0.0348}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0002},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.0668},{"period":"1year","weight":0.2246},{"period":"ytd","weight":0.0404}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海普瑞药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2010-05-06","address":"广东省深圳市南山区松坪山郎山路21号","registeredCapital":"146729万元","survey":"　　深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。","listedPrice":148}}}}

海普瑞(002399)

公司概况

热议股票